Trial intelligence / Profile preview

STOP: NA Cessation in Chronic Hepatitis B

NCT02581033Unknown

Sponsor
St Vincent's Hospital Melbourne
Start
May 2014
Primary completion
May 2018
Countries
1
01

Overview

Open-label, single-arm trial in Chronic Hepatitis B (CHB), sponsored by St Vincent's Hospital Melbourne. Primary endpoint: Sustained Virological Response at 24 months. Status: unknown.

02

Conditions

Chronic Hepatitis B (CHB)

Beyond the preview

Go deeper on NCT02581033.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02581033.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call